Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27299616 | 0.80 | TMEM97 (0.49) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL13130046 | 0.75 | CA2 (0.47) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL3488211 | 0.74 | CA2 (0.39) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL10972837 | 0.72 | ALDH1A1 (0.52) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL12059431 | 0.72 | ALDH1A1 (0.52) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL12349246 | 0.72 | GAA (0.45) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL7154999 | 0.71 | CA2 (0.50) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL18817541 | 0.71 | CA2 (0.50) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL10975960 | 0.71 | ALDH1A1 (0.55) | CA2ALDH1A1NPSR1 | |
| SCHEMBL20707235 | 0.71 | CA2 (0.41) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | disclosed |